Microbiota Transplant Therapy for GI Disorders – Adams Part 1 of 2
PDF Slides: https://www.dropbox.com/s/jo5mkpb7ppjmw54/Adams_James_052518.pdf?dl=0
We conducted a Phase 1 clinical trial of an Investigational New Drug involving 2 weeks of oral vancomycin (to kill unhealthy gut bacteria), followed by a bowel cleanse and then standardized human gut microbiota to create a healthy GI microbiome. We used FMT to treat children ages 7-17 years who had ASD and moderate or severe gastrointestinal problems. We administered FMT in two stages: an oral or rectal dose, followed by 8 weeks of oral administration. There was an 82% reduction in GI symptoms, and a 25% reduction in autism symptoms. Their bacterial diversity significantly increased, from 25% below normal to normal. At the 8-week follow-up, the improvements in GI symptoms, ASD symptoms, and microbiome diversity were stable.
James B. Adams, PhD